Spanish pharmaceutical firm Rovi raised on Wednesday its profitability targets for this year thanks to its contract to manufacture the COVID-19 vaccine developed by U.S.-based Moderna. Rovi said it expects its operating income to rose between 35% and 40% in 2021 from the previous year thanks to the Moderna vaccine, up from a previous target of between 20% and 30%. Rovi, which currently bottles and finishes the Moderna vaccine for most markets outside the U.S., signed a contract in April with the U.S. company to also manufacture active ingredients for the vaccine.

(Bloomberg) -- Rio Tinto Group, the world’s biggest iron ore miner, reported its highest-ever interim profit and said it will pay $9.1 billion in dividends as the company and its global rivals cash in on this year’s commodities rally.The company said its underlying earnings more than doubled to $12.2 billion from the same period last year. Rio will pay a regular interim dividend of $6.1 billion and a special dividend of $3 billion. Together, the half-year payout is more than the company returned